코스닥 이야기
Quickly browse recent reports in the selected category.
-
Alteogen (196170) Enters Era of Scale Milestone Revenues, First Year of Earnings Leap Proven by Royalty Inflows
Alteogen 196170 is set to enter a massive milestone inflow phase driven by its SC platform technology, with billions in cash expected from Keytruda SC...
-
KOSDAQ Flirts with 1,002 Level Amidst KOSPI's Rally past 8,000: Examining Bio/Healthcare ETF Inflows and Second-Half Recovery Scenarios
KOSDAQ faces decoupling at the 1,002.44 level as KOSPI rallies past 8,000. However, persistent K bio technology exports are driving steady inflows int...
-
KOSDAQ Anchors at 1,002 Level; Examining Classys' (214150) 15% US Revenue Target and Global Expansion Strategy
Global medical aesthetics leader Classys 214150 is accelerating its expansion in the US, the world's largest aesthetic medical market, presenting a lo...
-
KOSDAQ at 1,049: Exploring Clinical Trial Calendars Driven by ADA & Clinical Momentum alongside Valuations of Top 3 Leaders (Alteogen, ABL Bio, Peptron)
KOSDAQ looks to regain momentum with upcoming major conferences like ADA 2026. This article analyzes the technology, clinical calendars, and valuation...
-
KOSDAQ Closes at 1,026: Lithium Price Recovery Sparks Turnaround for Battery Material Stocks & Valuation Check for the Top 3 Cathode Makers
Daily Stock analyzes how the recent rebound in global lithium prices is driving a turnaround for KOSDAQ battery material stocks, featuring earnings su...
-
KOSDAQ at 1,020 Level: Checking Volatility Caused by Semiconductor Concentration and KOSDAQ Credit Balance Dipping Below 10 Trillion Won
KOSDAQ dips below 1,020 as its credit balance falls under 10 trillion won. DailyStock analyzes the K shaped polarization, liquidity drains, and risks ...